Editorial
Clinical benefit of treatment for metastatic renal cell cancer at high volume facilities
Abstract
Advancements in molecular biology and the ability to prime the immune system to target cancer cells have opened new frontiers in anti-cancer therapy, particularly in the metastatic setting.
